Endocrinology and Clinical Metabolic Research
A section of Metabolites (ISSN 2218-1989).
Section Information
Metabolites and metabolism have long been key parts of endocrinology and clinical metabolic research. This section of Metabolites now provides a venue to focus on these areas of investigation. In addition to those areas of traditional interest, such as precision medicine, biomarker discovery and inborn errors of metabolism, other clinically relevant areas will also be given full consideration.
These include, but are not limited to, original research and review articles on:
- metabolism in endocrine disorders
- cardio-metabolic risk
- fatty liver disease (NAFLD-NASH/MAFLD); cryptogenic and NAFLD-cirrhosis; NAFLD-HCC
- chronic kidney disease; fatty pancreas and gut microbiota
- adiposopathy and pathophysiology of adipose tissue
- immunity and metabolism
- metabolic derangements in infectious diseases
- sex medicine as applied to normal and deranged metabolism
- lifestyle and metabolism; chronometabolism; intermittent fasting
- biochemical and molecular characterization of pathophenotypes in internal medicine
In all these areas and many others, multidisciplinary and molecular approaches will represent added value. We hope our readers will appreciate the section “Endocrinology and Clinical Metabolic Research” and look forward to receiving high-quality scientific submissions from all over the world, while committing ourselves to the rapid and accurate processing of manuscripts.
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- The Multifaceted Roles of Biomarkers in Metabolic Disorders: From Diagnosis and Monitoring to Prediction, Management, and Treatment (Deadline: 15 August 2025)
- Metabolic Modulators in Cardiovascular Disease Management (Deadline: 31 August 2025)
- Targeting Microbiota and Metabolites for Prevention and Treatment of Human Diseases (Deadline: 31 August 2025)
- Diabetes and Metabolic Diseases: From Prevention to Clinical Management (Deadline: 31 August 2025)
- Hyperlipidemia Related Endocrine Disease and Cancer in Human and Animal (Deadline: 31 August 2025)
- Insulin Clearance and Metabolic Dysregulation in Health and Disease (Deadline: 31 August 2025)
- Amino Acid Metabolism in Angiogenesis (Deadline: 31 August 2025)
- Biomarkers and Human Blood Metabolites 2025 (Deadline: 30 September 2025)
- Metabolomics in Clinical Research: Advancing Precision Medicine Through the Analysis of Biological Samples (Deadline: 30 September 2025)
- Role of Metabolic Factors and Their Interactions on Diabetes and Its Complications (Deadline: 30 September 2025)
- Interactions of Diet, Exercise, and Metabolism (Deadline: 30 September 2025)
- Adrenal Neuroendocrine System and Cardiometabolic Health (Deadline: 30 September 2025)
- Exploring Pathological Mechanisms in Obesity, Diabetes, and Metabolic Syndrome (Deadline: 30 September 2025)
- The Interaction Between Metabolic Dysfunction and Hypothalamic Inflammation (Deadline: 31 October 2025)
- Flavonoids: Novel Therapeutic Potential for Chronic Diseases (Deadline: 31 October 2025)
- Research of Inborn Errors of Metabolism (Deadline: 31 October 2025)
- Metabolic Biomarkers and Nutrition in Degenerative Conditions and Gastrointestinal Cancer Surgery: 2nd Edition (Deadline: 31 October 2025)
- The Relationship Between Adipose Tissue Insulin Resistance and Metabolic Syndrome (Deadline: 15 November 2025)
- Sex Differences in Physical Exercise and Dietary Habits Effects on Metabolic Health (Deadline: 28 November 2025)
- Effects of Various Exercise Methods on Metabolic Health (Deadline: 28 November 2025)
- Imaging and Spectroscopic Based Methods to Understand Cancer Metabolism and Biology 2025 (Deadline: 30 November 2025)
- Exposome and Metabolic Effects: Neurological Implications of Environmental Pollutants (Deadline: 30 November 2025)
- Autophagy and Antioxidant Pathways in Neurodegenerative Diseases (Deadline: 30 November 2025)
- Mass Spectrometry-Based Metabolomics in Health and Disease: Targeted Analysis and Its Trends (Deadline: 30 November 2025)
- Metabolic Biomarkers in Type 2 Diabetes: From Discovery to Application (Deadline: 30 November 2025)
- Environmental Exposure and Its Effects on Cardio-Respiratory and Metabolic Health (Deadline: 30 November 2025)
- Advances in Gut Microbiome Metabolomics (Deadline: 1 December 2025)
- Metabolomics in Respiratory, Cardiovascular and Metabolic Disorders (Deadline: 1 December 2025)
- Metabolite Profiles in Inflammatory Diseases (Deadline: 15 December 2025)
- Obesity and Metabolic Syndrome in Children: Insights, Interventions and Emerging Perspectives, 2nd Edition (Deadline: 31 December 2025)
- Exploring Uric Acid and Beyond (Deadline: 31 December 2025)
- Effects of Chemical Exposure on Endocrine and Reproductive Functions, 2nd Edition (Deadline: 31 December 2025)
- Mitochondrial Metabolism, Redox State and Immunology in Cancer (Deadline: 31 December 2025)
- Advancing Metabolic/Microbial Biomarker Applications in Disease Prevention, Diagnosis and Public Health (Deadline: 31 December 2025)
- Role of Cell Metabolism in Infective Diseases (Deadline: 31 December 2025)
- Metabolomics and MASLD: Pathways, Biomarkers, and Clinical Insights (Deadline: 31 December 2025)
- Primary Hyperparathyroidism: Mechanisms and Treatment (Deadline: 31 December 2025)
- Obesity, Hormones, and Metabolic Complications in Pregnancy (Deadline: 31 December 2025)
- Cardiovascular Biomarkers and Metabolism in Cardiovascular Diseases (Deadline: 15 January 2026)
- Current Research in Metabolic Syndrome and Cardiometabolic Disorders (Deadline: 31 January 2026)
- Liver Injury and Regeneration—Metabolic Research (Deadline: 31 January 2026)
- Connections Between Nutrition, Epidemiology, and Metabolism (Deadline: 31 January 2026)
- Metabolic Dysregulation in Fatty Liver Disease (Deadline: 31 January 2026)
- Interactions Between Exercise Physiology and Metabolism (Deadline: 31 January 2026)
- Metabolism in Kidney Disease (Deadline: 15 February 2026)
- Role of Lipid Metabolism in Cardiovascular Health (Deadline: 16 February 2026)
- Effects of Nutrition and Exercise on Cardiometabolic Health (Deadline: 16 February 2026)
- Advances in Metabolomics for Precision Medicine: From Biomarker Discovery to Clinical Applications (Deadline: 28 February 2026)
- Exploring Metabolomic Signatures and the Metabolic Impact of Thyroid Dysfunction (Deadline: 28 February 2026)
- Metabolomics in Infectious Diseases (Deadline: 1 March 2026)
- Research on Metabolic Biomarkers in Different Diseases (Deadline: 16 March 2026)
- Obesity and Metabolic Dysfunction: Disease Development and Breaking the Cycle (Deadline: 31 March 2026)
- Endocrine Disruptors, Nutritional Modulators and Metabolic Pathways in PCOS: From Exposure to Intervention (Deadline: 31 March 2026)
- Metabolomics and Lipidomics in MASLD and Related Liver Disorders (Deadline: 1 April 2026)
Topical Collection
Following topical collection within this section is currently open for submissions:
